指南与共识眼底病与葡萄膜炎角膜与眼表疾病

COTS共识指南:前葡萄膜炎、中间葡萄膜炎、全葡萄膜炎及视网膜血管炎中启动抗结核治疗的规范

Collaborative Ocular Tuberculosis Study Consensus Guidelines on the Management of Tubercular Uveitis-Report 2: Guidelines for Initiating Antitubercular Therapy in Anterior Uveitis, Intermediate Uveitis, Panuveitis, and Retinal Vasculitis.
指南 / 共识 · Ophthalmology · 2020-06-27

TOPIC: The Collaborative Ocular Tuberculosis Study (COTS), supported by the International Ocular Inflammation Society, International Uveitis Study Group, and Foster Ocular Immunological Society, set up an international, expert-led consensus project to develop evidence- and experi…

要点

  • 复发性结核性前葡萄膜炎、中间葡萄膜炎、全葡萄膜炎及活动性视网膜血管炎,专家共识同意启动 ATT,取决于结核流行程度。
  • 任一免疫学试验阳性且影像学提示既往结核感染证据时,专家共识同意启动 ATT。
  • 首次发作的结核性前葡萄膜炎,仅当免疫学与影像学检查均阳性时,共识才同意启动 ATT。

核心结论

  • 指南建议将特定类型的结核性葡萄膜炎纳入应按结核病治疗的疾病列表,以指导公共卫生政策。

研究设计与样本

  • 采用两步改良 Delphi 技术,第一步通过基于文献背景证据的网络问卷收集 81 位国际专家对 324 个临床场景问题的意见。

主要发现

  • 共识声明基于提示结核性葡萄膜炎的眼部表型及多种免疫学与影像学检查结果组合提供的结核支持证据。

关键数值与推荐

  • 复发性结核性前葡萄膜炎、中间葡萄膜炎、全葡萄膜炎及活动性视网膜血管炎,专家共识同意启动 ATT,取决于结核流行程度。
  • 任一免疫学试验阳性且影像学提示既往结核感染证据时,专家共识同意启动 ATT。
  • 首次发作的结核性前葡萄膜炎,仅当免疫学与影像学检查结果均阳性时,共识才同意启动 ATT。

临床怎么用

  • 临床可依据眼部表型、免疫学与影像学检查结果组合及结核流行程度,分层决定是否启动 ATT。
  • 对复发性结核性前葡萄膜炎、中间葡萄膜炎、全葡萄膜炎及活动性视网膜血管炎,应结合结核流行程度评估启动 ATT。
  • 对首次发作的结核性前葡萄膜炎,需免疫学与影像学检查均阳性才考虑启动 ATT。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

TOPIC: The Collaborative Ocular Tuberculosis Study (COTS), supported by the International Ocular Inflammation Society, International Uveitis Study Group, and Foster Ocular Immunological Society, set up an international, expert-led consensus project to develop evidence- and experience-based guidelines for the management of tubercular uveitis (TBU). CLINICAL RELEVANCE: The absence of international agreement on the use of antitubercular therapy (ATT) in patients with TBU contributes to a significant heterogeneity in the approach to the management of this condition. METHODS: Consensus statements for the initiation of ATT in TBU were generated using a 2-step modified Delphi technique. In Delphi step 1, a smart web-based survey based on background evidence from published literature was prepared to collect the opinion of 81 international experts on the use of ATT in different clinical scenarios. The survey included 324 questions related to tubercular anterior uveitis (TAU), tubercular intermediate uveitis (TIU), tubercular panuveitis (TPU), and tubercular retinal vasculitis (TRV) administered by the experts, after which the COTS group met in November 2019 for a systematic and critical discussion of the statements in accordance with the second round of the modified Delphi process. RESULTS: Forty-four consensus statements on the initiation of ATT in TAU, TIU, TPU, and TRV were obtained, based on ocular phenotypes suggestive of TBU and corroborative evidence of tuberculosis, provided by several combinations of immunologic and radiologic test results. Experts agreed on initiating ATT in recurrent TAU, TIU, TPU, and active TRV depending on the TB endemicity. In the presence of positive results for any 1 of the immunologic tests along with radiologic features suggestive of past evidence of tuberculosis infection. In patients with a first episode of TAU, consensus to initiate ATT was reached only if both immunologic and radiologic test results were positive. DISCUSSION: The COTS consensus guidelines were generated based on the evidence from published literature, specialists' opinions, and logic construction to address the initiation of ATT in TBU. The guidelines also should inform public policy by adding specific types of TBU to the list of conditions that should be treated as tuberculosis.

来源:Ophthalmology,查看原文。版权归原作者所有。

引用

  1. Agrawal R, Testi I, Bodaghi B, et al. Collaborative Ocular Tuberculosis Study Consensus Guidelines on the Management of Tubercular Uveitis-Report 2: Guidelines for Initiating Antitubercular Therapy in Anterior Uveitis, Intermediate Uveitis, Panuveitis, and Retinal Vasculitis. Ophthalmology. 2020. PMID: 32603726. doi:10.1016/j.ophtha.2020.06.052

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。